Vamil Divan analyst GUGGENHEIM

Currently out of the existing stock ratings of Vamil Divan, 183 are a BUY (65.12%), 90 are a HOLD (32.03%), 8 are a SELL (2.85%).

Vamil Divan

Work Performance Price Targets & Ratings Chart

Analyst Vamil Divan works at GUGGENHEIM with a stock forecast success ratio of 61.57% fulfilled within 211.75 days on average.

Vamil Divan’s has documented 594 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TVTX, Travere Therapeutics at 27-Mar-2024.

Wall Street Analyst Vamil Divan

Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for PFE (PFIZER) at 11/4/2021. The price target of $44 was fulfilled within 1 day with a profit of $3.97 (9.92%) receiving and performance score of 99.18.

Average potential price target upside

ABBV AbbVie ACAD ACADIA Pharmaceuticals AGN Allergan plc ALKS Alkermes Plc AXSM Axsome Therapeutics BHVN Biohaven Pharmaceutical Holding Co Ltd EOLS Evolus KRTX Karuna Therapeutics LLY Eli Lilly and Company NBIX Neurocrine Biosciences PFE Pfizer PTLA Portola Pharmaceuticals SAGE Sage Therapeutic STSA Satsuma Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR AIMT Aimmune Therapeutics BMY Bristol-Myers Squibb Company JNJ Johnson & Johnson CABA Cabaletta Bio CFRX ContraFect Corp RVNC Revance The AVTE Aerovate Therapeutics CALT Calliditas Therapeutics CRVS Corvus Pharmaceuticals ESPR Esperion Therapeutics GLPG Galapagos NV ADR GOSS Gossamer Bio IRWD Ironwood Pharmaceuticals KDNY Chinook Therapeutics MRK Merck mpany RLMD Relmada Therapeutics SCYX Scynexis TVTX Travere Therapeutics MGTA Magenta Therapeutics XERS Xeris Pharmaceuticals ANIP ANI Pharmaceuticals INSM Insmed

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

195

$25.2 (14.84%)

185

17 days ago

10/12 (83.33%)

$14.65 (8.12%)

191

Buy

189

$19.2 (11.31%)

181

2 months 7 days ago

9/11 (81.82%)

$15.71 (9.07%)

252

Buy

195

$25.2 (14.84%)

180

2 months 7 days ago

9/10 (90%)

$21.71 (12.53%)

445

Hold

165

$-4.8 (-2.83%)

157

2 months 27 days ago

11/11 (100%)

$2.96 (1.83%)

314

Buy

180

$10.2 (6.01%)

195

3 months 10 days ago

3/5 (60%)

$21.06 (13.25%)

496

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Vamil Divan is most bullish on?

Potential upside of $25.89 has been obtained for INSM (INSMED)

Which stock is Vamil Divan is most reserved on?

Potential downside of -$84.83 has been obtained for KRTX (KARUNA THERAPEUTICS)

What Year was the first public recommendation made by Vamil Divan?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?